UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 991

Sortiert nach

NASH pour l’endocrinologue

Annales d'endocrinologie, 2020-09, Vol.81 (4), p.142-142

2020

Link zum Volltext

Verfügbarkeit prüfen

P1030 STATEMENT FOR REPORTING STUDIES OF DIAGNOSTIC ACCURACY ON LIVER FIBROSIS TESTS

Journal of hepatology, 2014-04, Vol.60 (1), p.S418-S418

Boursier, J

2014

Link zum Volltext

Verfügbarkeit prüfen

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Nature Medicine, 2021-10, Vol.27 (10), p.1825-1835

2021

Link zum Volltext

Verfügbarkeit prüfen

Stéatose hépatique dans le syndrome de Cushing : évaluation par tomodensitométrie

Annales d'endocrinologie, 2022-10, Vol.83 (5), p.322-323

2022

Link zum Volltext

Verfügbarkeit prüfen

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C – authors’ reply

Alimentary pharmacology & therapeutics, 2017-05, Vol.45 (9), p.1276-1277

2017

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software

European radiology, 2023-12, Vol.33 (12), p.8999-9009

2023

Link zum Volltext

Verfügbarkeit prüfen

Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis

Gut, 2015-07, Vol.64 (7), p.1148-1157

2015

Link zum Volltext

Verfügbarkeit prüfen

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Alimentary Pharmacology & Therapeutics (Suppl), 2018-05, Vol.47 (10), p.1387-1396

2018

Link zum Volltext

Verfügbarkeit prüfen

Étude de l’impact de la progression de la fibrose hépatique chez les patients atteints de « non-alcoholic fatty liver disease

Revue d'épidémiologie et de santé publique, 2020-09, Vol.68, p.S140-S141

2020

Link zum Volltext

Verfügbarkeit prüfen

P1015 COMBINATION OF BLOOD MARKERS TARGETED FOR DIFFERENT FIBROSIS STAGES OUTPERFORMS LIVER BIOPSY FOR PROGNOSTICATION IN HEPATITIS C

Journal of hepatology, 2014-04, Vol.60 (1), p.S413-S413

2014

Link zum Volltext

Verfügbarkeit prüfen

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Alimentary pharmacology & therapeutics, 2017-04, Vol.45 (7), p.991-1003

2017

Link zum Volltext

Verfügbarkeit prüfen

Screening of large esophageal varices by a simple algorithm of blood markers

Journal of hepatology, 2017, Vol.66 (1), p.S565-S566

2017

Link zum Volltext

Verfügbarkeit prüfen

Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance

Diagnostic and interventional imaging, 2017-06, Vol.98 (6), p.455-468

2017

Link zum Volltext

Verfügbarkeit prüfen

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

Alimentary pharmacology & therapeutics, 2014-07, Vol.40 (2), p.178-188

2014

Link zum Volltext

Verfügbarkeit prüfen

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults

Diabetes & metabolism, 2016-11, Vol.42 (5), p.364-367

2016

Link zum Volltext

Verfügbarkeit prüfen

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Journal of hepatology, 2017, Vol.66 (1), p.S669-S670

2017

Link zum Volltext

Verfügbarkeit prüfen

Association entre le SAHOS et la fibrose hépatique chez les patients pris en charge pour une stéatose hépatique non alcoolique

Revue des maladies respiratoires actualités, 2024-01, Vol.16 (1), p.4-5

2024

Link zum Volltext

Verfügbarkeit prüfen

Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD)

Revue d'épidémiologie et de santé publique, 2020-09, Vol.68, p.S130-S130

2020

Link zum Volltext

Verfügbarkeit prüfen

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

Journal of hepatology, 2016, Vol.64 (2), p.S736-S737

2016

Link zum Volltext

Verfügbarkeit prüfen

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

Journal of hepatology, 2011-03, Vol.54, p.S130-S130

2011

Link zum Volltext

Verfügbarkeit prüfen

O017 : Effectiveness of treatment initiation based on fibrosis stage assessed by methods of fibrosis diagnosis in terms of 5-year incidence of morbi-mortality

Journal of hepatology, 2015-04, Vol.62, p.S198-S198

2015

Link zum Volltext

Verfügbarkeit prüfen

Molten salt/liquid metal extraction: Electrochemical determination of activity coefficients in liquid metals

Journal of nuclear materials, 2005-09, Vol.344 (1), p.165-168

2005

Link zum Volltext

Verfügbarkeit prüfen

Non-Invasive Tests for the Diagnosis of Liver Fibrosis are also Prognostic Markers in Non-Alcoholic Fatty Liver Disease

Journal of hepatology, 2016, Vol.64 (2), p.S484-S484

2016

Link zum Volltext

Verfügbarkeit prüfen

Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis

Journal of hepatology, 2017, Vol.66 (1), p.S69-S69

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 991

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(771)
Mit Volltextzugriff
(853)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

NASH pour l’endocrinologue

P1030 STATEMENT FOR REPORTING STUDIES OF DIAGNOSTIC ACCURACY ON LIVER FIBROSIS TESTS

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial

Stéatose hépatique dans le syndrome de Cushing : évaluation par tomodensitométrie

Editorial: combining elastography with blood test for fibrosis assessment in chronic hepatitis C – authors’ reply

Evaluation of proton density fat fraction (PDFF) obtained from a vendor-neutral MRI sequence and MRQuantif software

Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis

Screening for therapeutic trials and treatment indication in clinical practice: MACK‐3, a new blood test for the diagnosis of fibrotic NASH

Étude de l’impact de la progression de la fibrose hépatique chez les patients atteints de « non-alcoholic fatty liver disease

P1015 COMBINATION OF BLOOD MARKERS TARGETED FOR DIFFERENT FIBROSIS STAGES OUTPERFORMS LIVER BIOPSY FOR PROGNOSTICATION IN HEPATITIS C

Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?

Screening of large esophageal varices by a simple algorithm of blood markers

Liver fibrosis, cirrhosis, and cirrhosis-related nodules: Imaging diagnosis and surveillance

Combination of blood tests for significant fibrosis and cirrhosis improves the assessment of liver‐prognosis in chronic hepatitis C

Osteoprotegerin levels are associated with liver fat and liver markers in dysmetabolic adults

How to combine blood test and elastography to stage liver fibrosis in chronic hepatitis C?

Association entre le SAHOS et la fibrose hépatique chez les patients pris en charge pour une stéatose hépatique non alcoolique

Diagnostic non invasif de cirrhose dans la « non-alcoholic fatty liver disease » (NAFLD)

Liver Fibrosis Diagnosis by Blood Test and Elastography: Agreement or Combination?

324 COMPARISON OF DIAGNOSTIC ALGORITHMS FOR LIVER FIBROSIS IN HEPATITIS C. NEW ALGORITHMS ARE AS EFFECTIVE WHILE MORE PRECISE AND TOTALLY NON-INVASIVE

O017 : Effectiveness of treatment initiation based on fibrosis stage assessed by methods of fibrosis diagnosis in terms of 5-year incidence of morbi-mortality

Molten salt/liquid metal extraction: Electrochemical determination of activity coefficients in liquid metals

Non-Invasive Tests for the Diagnosis of Liver Fibrosis are also Prognostic Markers in Non-Alcoholic Fatty Liver Disease

Validation of the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease: an individual patient meta-analysis

Suchergebnisse filtern